Skip to main content

Month: August 2022

MDxHealth Reports Half Year 2022 Results

NEWS RELEASE – REGULATED INFORMATION25 AUGUST 2022, 4:00PM EDT, 22:00 CET MDxHealth Reports Half Year 2022 Results IRVINE, CA, and HERSTAL, BELGIUM – August 25, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH) (“mdxhealth” or the “Company“), a commercial-stage precision diagnostics company, today announced its financial results for the half year ended June 30, 2022. Michael K. McGarrity, CEO of mdxhealth, commented: “We are excited to report strong operating results for the first half of 2022, coupled with our recently announced acquisition of the Oncotype DX GPS business from Exact Sciences. Our first half 2022 performance reflects the continued execution of our growth strategy and provides a strong foundation for driving sustained growth for mdxhealth.” Key Financial and Corporate Highlights for the half year...

Continue reading

Crown Castle to Present at the Bank of America 2022 Media, Communications & Entertainment Conference

HOUSTON, Aug. 25, 2022 (GLOBE NEWSWIRE) — Crown Castle Inc. (NYSE: CCI) (“Crown Castle”) announced today that Dan Schlanger, Crown Castle’s Executive Vice President and Chief Financial Officer, is scheduled to present on Thursday, September 8, 2022 at 12:40 p.m. Eastern Time at the Bank of America 2022 Media, Communications & Entertainment Conference. The presentation will be broadcast live over the Internet and is expected to last approximately 40 minutes. The live audio webcast link and presentation for the conference will be available on Crown Castle’s website at www.crowncastle.com, where it will also be archived for replay. ABOUT CROWN CASTLE Crown Castle owns, operates and leases more than 40,000 cell towers and approximately 85,000 route miles of fiber supporting small cells and fiber solutions across every...

Continue reading

Kane Biotech Announces Second Quarter 2022 Financial Results

Significant Milestones Achieved WINNIPEG, Manitoba, Aug. 25, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its second quarter 2022 financial results. Second Quarter Financial Highlights:Total revenue for the three months ended June 30, 2022 was $839,579, an increase of 201% compared to $278,741 in the three months ended June 30, 2021.License revenue in the three months ended June 30, 2022 was $500,225, an increase of 1,295% compared to $35,872 in the three months ended June 30, 2021. This substantial increase is due to the Company’s subsidiary, STEM Animal Health, achieving a key milestone in April, 2022, namely the Veterinary Oral Health Council (“VOHC”) Seal of Acceptance in the Helps Control Tartar category, which triggered approximately $1.3 million...

Continue reading

Reviv3 Procare Reports Record 2022 Financial Results and Provides Business Updates

Record Fiscal Year 2022 revenue of $2.3 Million reflects 43% year-over-year growth. Company expects revenue for Q1 ending August 31, 2022 exceeding $3.4 Million, a substantial increase compared to the same prior year period, primarily as a result of the previously announced asset acquisition of AXIL & Associated Brands. LOS ANGELES, Aug. 25, 2022 (GLOBE NEWSWIRE) — Reviv3 Procare Company (OTCQB: RVIV), an emerging global e-commerce brand in hair care products industry and hearing protection and enhancement products, today announced its financial and operational results for fiscal year ended May 31, 2022. Fiscal Year End 2022 Financial SummaryRevenues increased 43% to $2,336,257 compared to $1,633,609 in the previous year, primarily driven by our marketing initiatives in the direct-to-consumer sales channels. Gross profit...

Continue reading

Alpha Tau Medical Announces Second Quarter 2022 Financial Results and Provides Corporate Update

–Received FDA Conditional Investigational Device Exemption (IDE), whose conditions have since been satisfied, to initiate a pivotal trial of Alpha DaRT™ in recurrent cutaneous squamous cell carcinoma. The Company expects to treat its first patient in this study later in 2022– –Treated first patient in a feasibility study evaluating the Alpha DaRT as a neoadjuvant therapy in patients with prostate cancer- JERUSALEM, Aug. 25, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS and DRTSW), (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, reported second quarter 2022 financial results and provided a corporate update. “We have made significant progress by gaining conditional FDA approval, whose conditions have since been satisfied,...

Continue reading

Lantronix Reports Record Results for Fourth Quarter and Fiscal 2022

Fourth Quarter Net Revenue of $35.9 Million, up 74 Percent Year-Over-Year Fourth Quarter GAAP EPS of $0.07 vs. ($0.04) in the Prior Year Fourth Quarter Non-GAAP EPS of $0.08 vs. $0.06 in the Prior Year Initiates Full Year Fiscal 2023 Revenue Guidance to a range of $149 Million to $162 MillionIRVINE, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for Intelligent IT and Internet of Things (IoT), today reported record results for its fourth quarter of fiscal 2022. Net revenue totaled $35.9 million, up 74 percent year-over-year and up 11 percent sequentially. GAAP EPS of $0.07, compared to ($0.04) in the prior year and ($0.09) in the prior quarter. Non-GAAP EPS of $0.08, compared to $0.06 in the prior year and $0.08 in the prior quarter. Business Outlook While...

Continue reading

Applied Blockchain Reports Fiscal Fourth Quarter and Full Year 2022 Financial Results and Provides an Operational Update

DALLAS, Aug. 25, 2022 (GLOBE NEWSWIRE) — Applied Blockchain, Inc. (Nasdaq: APLD) (“Applied Blockchain” or the “Company”) today reported financial results for the fiscal fourth quarter and full year ended May 31, 2022, and provided an operational update. Recent Operational and Financial HighlightsFiscal fourth quarter revenue of $7.5 million, above guidance of $7.0 million to $7.4 million, which was increased in mid-July from original guidance of $5.7 million to $6.2 million. Power provider to our facility in Jamestown, North Dakota, completed substation repairs ahead of schedule; facility is now operating at full capacity. Secured a five-year hosting contract with Marathon Digital Holdings, Inc. for 200MW of capacity. Secured a $15.0 million credit facility with a North Dakota-based bank with 1.5% interest...

Continue reading

Sumo Logic Announces Second Quarter Fiscal 2023 Financial Results

Second quarter revenue grew 26% year over year to $74.1 millionSecond quarter ARR grew 25% year over year to $286.2 million REDWOOD CITY, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) — Sumo Logic (NASDAQ: SUMO), the SaaS analytics platform to enable reliable and secure cloud-native applications, today announced financial results for the second quarter of its fiscal 2023 ended July 31, 2022. “We continued to deliver improved revenue growth in the second quarter with year-over-year growth of 26% while also driving better operating efficiencies,” said Ramin Sayar, President and CEO of Sumo Logic. “We remain positive on the long term trends driving our business as companies continue to focus on delivering reliable and secure mission critical cloud applications for their customers.” Second Quarter Fiscal 2023 Financial HighlightsRevenue...

Continue reading

Mobile broadband penetration in Latin America could create 6.5 million jobs and lift GDP per capita by 1.7%

Mobile broadband penetration in Latin America could create 6.5 million jobs and lift GDP per capita by 1.7%  LUXEMBOURG, August 25, 2022 – According to an independent study conducted by Telecom Advisory Services, commissioned by Millicom (Tigo), a 10% increase in mobile broadband penetration in Latin America could create more than 6.5 million jobs and increase GDP per capita by 1.7%. The study “The Role of the Digital Economy in the Economic Recovery of Latin America and the Caribbean” was authored by Raul Katz, Ph.D., Juan Jung, Ph.D., and Fernando Callorda, MA, from Telecom Advisory Services. The findings show a significant opportunity for a region that is still struggling to recover from the economic impact of the COVID-19 pandemic. The analysis identifies high spectrum costs – a common regional issue – as the biggest hurdle to digitalization....

Continue reading

Gulf Coast Sand Acquires Shale Support Assets

Move Makes Company the Largest Independent Aggregate Provider and Supplier Along the Gulf Coast BATON ROUGE, La., Aug. 25, 2022 (GLOBE NEWSWIRE) — Gulf Coast Sand (GCS), the largest privately-owned and independent producer and supplier for specialized sands, blended sands, abrasives, and gravel, today announces it’s acquisition of the assets originating from Shale Support, LLC. With this move, GCS establishes itself as the largest independent, privately-owned aggregate company along the Gulf Coast and boasts more than 900 mineable acres of aggregate reserves. Additionally, the acquisition provides GCS two fluid bed driers, 10 mineral separators, and 24,000 thousand tons of silo storage, all paired with truck and unit rail train load out capabilities. These assets will also allow the company to have the ability to provide local...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.